demonstrated that the reintroduction of the HPS1 gene into lung fibroblasts isolated from HPS patients could reduce galectin‐3 levels, a pulmonary fibrosis marker, thus confirming that the reintroduction of the functional form of the gene can revert the disease phenotype [145]. This evidence concerns the gene HPS1 and pulmonary fibrosis.